Lanean...
Alectinib, Ceritinib, Elotuzumab, and Venetoclax
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and inve...
Gorde:
| Argitaratua izan da: | Hosp Pharm |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Thomas Land Publishers, Inc.
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4981100/ https://ncbi.nlm.nih.gov/pubmed/27559185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5107-524 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|